Sort
23,748 grants matching “melanoma”
Strategies to target BCR-ABL1 compound mutants in CML and Ph+ ALL
$358,566Michael W Deininger · Versiti Wisconsin, Inc. · R01 · FY2024 · CA
Basal Cell Carcinoma:Molecular Pathogenesis &Prevention
$358,511Columbia University Health Sciences · R01 · FY2002 · CA
MITF: master regulator of melanocyte development, pigmentation, and UV-related skin disease risk
$358,498David E Fisher · Massachusetts General Hospital · R01 · FY2022 · AR
Skin Cancer in Organ Transplant Recipients
$358,490Ervin H Epstein · University Of California, San Francisco · P01 · FY2007 · AR
Novel Receptor-Targeting Peptides for Melanoma Therapy
$358,488Yubin Miao · University Of Colorado Denver · R01 · FY2018 · CA
The genetic Basis of Melanoma Metastasis
$358,437Lynda Chin · Dana-Farber Cancer Inst · R01 · FY2011 · CA
A novel T-cell subset able to kill relapsed cancers
$358,347Qing Yi · Methodist Hospital Research Institute · R01 · FY2019 · CA
Targeting the developmental pathways Notch and ERBB for melanoma therapy
$358,346Barbara Bedogni · Case Western Reserve University · R01 · FY2015 · CA
Inhibition of GTPases and G proteins to treat human disease
$358,307John E Sondek · Univ Of North Carolina Chapel Hill · R01 · FY2019 · GM
Inhibition of GTPases and G proteins to treat human disease
$358,307John E Sondek · Univ Of North Carolina Chapel Hill · R01 · FY2017 · GM
Inhibition of GTPases and G proteins to treat human disease
$358,307John E Sondek · Univ Of North Carolina Chapel Hill · R01 · FY2016 · GM
Biospecimen and Pathology Core
$358,305Xiaowei Xu · Wistar Institute · P50 · FY2016 · CA
Mechanisms linking hemostatic factors and malignancy
$358,265Children'S Hospital Med Ctr (Cincinnati) · R01 · FY2003 · HL
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
$358,233Rajesh Agarwal · University Of Colorado Denver · R01 · FY2019 · CA
CELLULAR RESPONSES TO A VITRONECTIN MATRIX
$358,230Scripps Research Institute · R01 · FY2001 · CA
Control of Alphavirus Replication in the Nervous System
$358,203Diane E Griffin · Johns Hopkins University · R01 · FY2007 · NS
Integrative Cancer Genomics: Drivers, Pathways and Drugs
$358,131Dana Pe'er · Columbia Univ New York Morningside · R01 · FY2013 · CA
Multiplex matrix ELISA for T cell protein-interaction networks in cancer
$358,081Adam G. Schrum · University Of Missouri-Columbia · R33 · FY2020 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$357,994Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$357,994Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA
Role of Sirt2 in T Cell Metabolism
$357,994Sungjune Kim · Mayo Clinic Jacksonville · R37 · FY2025 · CA
Targeting TIGIT and PD-1 in Melanoma
$357,994Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Targeting TIGIT and PD-1 in Melanoma
$357,994Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Metabolic Reprogramming of Tumor Infiltrating Lymphocytes for Adoptive Immunotherapy
$357,994Udai S Kammula · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA
Mechanisms of UV-Mediated Melanoma Development
$357,986Christin E Burd · Ohio State University · R01 · FY2021 · CA